DNA Link and Amplicon Express have entered an agreement to develop genomic services.

Under the agreement, Amplicon Express will be responsible to extract high molecular weight DNA samples from bacteria, plants, animals and humans, while DNA Link will use the samples to develop a library for PacBio sequencing for genome analysis.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The agreement enables the two partners to further develop nucleic acid extraction process, library preparation and PacBio sequencing.

Proteomics International Laboratories plans to enter an agreement with Linear Clinical Research to develop an advanced analytical testing and clinical trials package.

The two partners will jointly work to expand their presence in the biopharmaceutical and oncology markets.

"The agreement enables the two partners to offer end-to-end testing and clinical trial services to their clients."

The agreement enables the two partners to offer end-to-end testing and clinical trial services to their clients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Kamada and Yissum Research Development Company of Hebrew University of Jerusalem have entered an agreement to develop recombinant human Alpha 1 Antitrypsin.

The agreement enables the partners to increase the protein yields and functionality.

Neovacs has announced to acquire interferon alpha (IFNa) manufacturing technology from Amega Biotech.

The acquisition enables Neovacs to further advance the clinical development and commercialisation strategy of IFNalpha Kinoid vaccine to treat lupus.

Pfizer plans to raise gross proceeds of $1.75bn through the public offering of 3% notes due 2026.

Citigroup Global Markets, Credits Suisse Securities (USA), Merrill Lynch, Pierce, Fenner & Smith, and RBC Capital Markets are acting as joint book running managers for the offering.

The company plans to use the funds to purchase tender notes and for general corporate purposes.

Image: Pfizer plans to raise gross proceeds of $1.75bn through the public offering of 3% notes. Photo: courtesy of Kultur Enis via Wikipedia.